Evidence map›Paper›PMID 38329124›Full record

ArticleJCI insight2024

Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease.

John L Johnson, Davit Sargsyan, Eric M Neiman, Amy Hart, Aleksandar Stojmirovic, Roman Kosoy, Haritz Irizar, Mayte Suárez-Fariñas, Won-Min Song, Carmen Argmann and 11 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07400211 (Non-invasive Molecular Diagnostics for Inflammatory Bowel Disease), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07400211 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Non-invasive Molecular Diagnostics for Inflammatory Bowel Disease : A Genetic and Biomarkers Study

TypeobservationalSponsorAssiut UniversityRan2026 to 2028Enrolled62ConditionsInflammatory Bowel Disease (IBD)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Non-coding RNA · 2025
    Review
  7. Article
  8. lncRNALife science alliance · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

John L JohnsonJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Davit SargsyanJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Eric M NeimanJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Amy HartJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Aleksandar StojmirovicJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Roman KosoyDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute for Data Science and Genomic Technology, New York, New York, USA.
Haritz IrizarDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute for Data Science and Genomic Technology, New York, New York, USA.
Mayte Suárez-FariñasDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute for Data Science and Genomic Technology, New York, New York, USA.
Won-Min SongDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute for Data Science and Genomic Technology, New York, New York, USA.
Carmen ArgmannDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute for Data Science and Genomic Technology, New York, New York, USA.
Stefan AveyJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Liraz Shmuel-GaliaProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Tim VierbuchenProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Gerold BongersJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Yu SunJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Leonard EdelsteinJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Jacqueline PerrigoueJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Jennifer E TowneJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Aisling O'Hara HallImmunology Translational Early Development, Bristol Myers Squibb, Summit, New Jersey, USA.
Katherine A FitzgeraldProgram in Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Kasper HoebeJohnson & Johnson Innovative Medicine, Spring House, Pennsylvania, USA.
Johnson & Johnson (United States) · USIcahn School of Medicine at Mount Sinai · USUniversity of Massachusetts Chan Medical School · USBristol-Myers Squibb (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of long noncoding RNAs (lncRNAs) in disease is incompletely understood, but their regulation of inflammation is increasingly appreciated. We addressed the extent of lncRNA involvement in inflammatory bowel disease (IBD) using biopsy-derived RNA-sequencing data from a large cohort of deeply phenotyped patients with IBD. Weighted gene correlation network analysis revealed gene modules of lncRNAs coexpressed with protein-coding genes enriched for biological pathways, correlated with epithelial and immune cell signatures, or correlated with distal colon expression. Correlation of modules with clinical features uncovered a module correlated with disease severity, with an enriched interferon response signature containing the hub lncRNA IRF1-AS1. Connecting genes to IBD-associated single nucleotide polymorphisms (SNPs) revealed an enrichment of SNP-adjacent lncRNAs in biologically relevant modules. Ulcerative colitis-specific SNPs were enriched in distal colon-related modules, suggesting that disease-specific mechanisms may result from altered lncRNA expression. The function of the IBD-associated SNP-adjacent lncRNA IRF1-AS1 was explored in human myeloid cells, and our results suggested IRF1-AS1 promoted optimal production of TNF-α, IL-6, and IL-23. A CRISPR/Cas9-mediated activation screen in THP-1 cells revealed several lncRNAs that modulated LPS-induced TNF-α responses. Overall, this study uncovered the expression patterns of lncRNAs in IBD that identify functional, disease-relevant lncRNAs.

Indexed as

Colitis, UlcerativeRNA, Long NoncodingGene Regulatory NetworksHumansInflammationTumor Necrosis Factor-alphaRNA, Long NoncodingTumor Necrosis Factor-alphaAutoimmune diseasesCellular immune responseGastroenterologyImmunologyMolecular genetics

Identifiers

PMID38329124
PMCPMC10967393
OpenAlexW4392454122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.